- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
AIDS: birth transmission falls
Transmission of AIDS from mothers to their infants fell 67% between 1992 and 1997, according to an article in the Journal of the American Medical Association.
Transmission of AIDS from mothers to their infants fell 67% between 1992 and 1997, according to an article in the Journal of the American Medical Association (vol. 282, no. 6).
Mary Lou Lindegren, from the Centers for Disease Control and Prevention in Atlanta, and colleagues analyzed national AIDS and HIV surveillance data through June 1998. In particular, the researchers studied the effects of the U.S. Public Health Service perinatal HIV recommendations on trends in incidence of perinatal AIDS and factors contributing to those trends.
The author found that rates of AIDS among infants declined 69% from 1992 to 1996, while births to HIV-infected women declined by only 17% from 1992 to 1995. According to the authors, the declines in perinatal AIDS were associated with an increase in the use of zidovudine (AZT) to reduce perinatal HIV transmission. The authors refuted claims that the decline can be written off as the result of reductions in the total number of births or the effect of new therapies in delaying AIDS.
In the article, the authors also suggest that to further reduce perinatal transmission, "we need comprehensive strategies to ensure access to prenatal care, HIV counseling and testing; therapy to reduce perinatal transmission; avoidance of breastfeeding; and appropriate treatment and services for mothers."
The authors concluded: "Prevention of HIV infection in women is the ultimate goal to further reduce perinatal HIV infection." PR
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
To Tackle the Plastic Waste Crisis in Pharma, Here’s Where to Start
October 30th 2024By demonstrating big advancements in recycling, pharma companies will be much more likely to attract shareholders and other investors, giving themselves a leg up in the competition to lead the biopharmaceutical industry well into the future.
